Evidence map›Paper›PMID 41486068›Full record

ArticleCancer science2026

Longitudinal Impact of Urinary Diversion on Health-Related Quality of Life After Radical Cystectomy: A Multicenter Study in Japan.

Shuhei Yamada, Miho Sato, Takahiro Osawa, Toru Harabayashi, Jun Miki, Takashi Kobayashi, Katsuyoshi Hashine, Atsunari Kawashima, Takashi Matsumoto, Takanori Mochizuki and 23 more

Abstract readMulticenter Study
In one paragraph

Article in Cancer science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Shuhei YamadaDepartment of Urology, Hokkaido University Hospital, Sapporo, Japan.
Miho SatoFaculty of Health Sciences, Hokkaido University, Sapporo, Japan.ORCID https://orcid.org/0000-0002-5715-0566
Takahiro OsawaDepartment of Urology, Hokkaido University Hospital, Sapporo, Japan.ORCID https://orcid.org/0000-0003-4444-7958
Toru HarabayashiDepartment of Urology, National Hospital Organization, Hokkaido Cancer Center, Sapporo, Japan.
Jun MikiDepartment of Urology, The Jikei University School of Medicine, Jikei Kashiwa Hospital, Kashiwa, Japan.
Takashi KobayashiDepartment of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.ORCID https://orcid.org/0000-0003-1069-2816
Katsuyoshi HashineDepartment of Urology, National Hospital Organization Shikoku Cancer Center, Ehime, Japan.
Atsunari KawashimaDepartment of Urology, Graduate School of Medicine, The University of Osaka, Osaka, Japan.ORCID https://orcid.org/0000-0001-9369-4264
Takashi MatsumotoDepartment of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Takanori MochizukiDepartment of Urology, University of Yamanashi Graduate School of Medical Sciences, Chuo, Japan.
Rikiya TaokaDepartment of Urology, Faculty of Medicine, Kagawa University, Miki-cho, Japan.
Fumihiko UrabeDepartment of Urology, The Jikei University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0002-2599-8183
Shuichi TataranoDepartment of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
Atsuro SawadaDepartment of Urology, University of Miyazaki, Miyazaki, Japan.
Takahiro KojimaDepartment of Urology, Aichi Cancer Center, Aichi, Japan.
Atsushi TakahashiDepartment of Urology, Hakodate Goryoukaku Hospital, Hakodate, Japan.
Akira YokomizoDepartment of Urology, Harasanshin Hospital, Fukuoka, Japan.ORCID https://orcid.org/0000-0002-5741-6280
Shigetaka SuekaneDepartment of Urology, Kurume University School of Medicine, Kurume, Japan.
Kohei HashimotoDepartment of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Yasuhiro HashimotoDepartment of Urology, Hirosaki University School of Medicine, Hirosaki, Japan.
Junji YatsudaDepartment of Urology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Ken MoritaDepartment of Urology, Kushiro City General Hospital, Kushiro, Japan.
Keita KobayashiDepartment of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Japan.
Yohei SatakeDepartment of Urology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Ataru SazawaDepartment of Urology, Obihiro Kosei Hospital, Obihiro, Japan.
Yoshiyuki MatsuiDepartment of Urology, National Cancer Center Hospital, Tokyo, Japan.
Yoichi M ItoData Science Center, Promotion Unit, Institute of Health Science Innovation for Medical Care, Hokkaido University Hospital, Sapporo, Japan.
Sayaka ShimizuPatient Driven Academic League (PeDAL), Tokyo, Japan.
Shunichi FukuharaSection of Clinical Epidemiology, Department of Community Medicine Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Hiroyuki NishiyamaDepartment of Urology, Faculty of Medicine University of Tsukuba, Tsukuba, Japan.ORCID https://orcid.org/0000-0001-7423-596X
Hiroshi KitamuraDepartment of Urology, University of Toyama, Toyama, Japan.
Nobuo ShinoharaDepartment of Urology, Hokkaido University Hospital, Sapporo, Japan.ORCID https://orcid.org/0000-0002-6695-294X
Japanese Urological Oncology Group

Funding

Japan Urological Association, Young Researcher Promotion Grant 2019-67
6 · The paper itself

Abstract

This multicenter longitudinal study was conducted across 24 institutions in Japan to examine the impact of urinary diversion on health-related quality of life (HRQOL) among bladder cancer patients who underwent radical cystectomy (RC). We evaluated bladder cancer-specific HRQOL and general HRQOL via the bladder cancer index (BCI) and the QOL General (QGEN-8), respectively, before the operation and at 3, 6, and 12 months postoperatively. The scores were compared across urinary diversion groups as well as across different time points within each urinary diversion group with linear mixed-effects models. Data from 227 patients were analyzed (151 with ileal conduits, 45 with ureterostomy, and 31 with neobladders). Neobladder patients were more likely to experience longitudinal impacts of their urinary diversion on urinary function than ileal conduit or ureterostomy patients were. Compared with that at baseline, the bowel function of neobladder patients remained impaired 12 months after surgery. All urinary diversion groups had worse sexual function scores at 3 and 6 months than at baseline, and the ileal conduit and neobladder groups had significantly worse sexual function scores at 12 months than at baseline. On the other hand, there was no significant difference in bother scores in the urinary, bowel, or sexual domain. The generic HRQOL was maintained from the preoperative to the postoperative period in all urinary diversion groups. This study explored longitudinal changes in HRQOL after RC, and the findings may help inform patient counseling regarding possible QOL trajectories.

Indexed as

CystectomyQuality of LifeUrinary Bladder NeoplasmsUrinary DiversionAgedAged, 80 and overFemaleHumansJapanLongitudinal StudiesMaleMiddle AgedBladder cancerbladder cancer indexhealth‐related quality of lifeprospective studyradical cystectomy

Identifiers

PMID41486068
PMCPMC12951116

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.